Z-0682-2019 Class II Terminated
FDA device recall Z-0682-2019 was initiated by Radiometer America Inc on Jul 3, 2018 and is designated Class II. Reason for recall: The analyzer software may cause a mis-match of patient demographics and test results when a certain sequence of events occur. The recall status is terminated (terminated Aug 30, 2023). Affected quantity: 2,131 analyzers.
Recall details
- Product Type
- Devices
- Report Date
- Jan 2, 2019
- Initiation Date
- Jul 3, 2018
- Termination Date
- Aug 30, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,131 analyzers
Product description
ABL800 analyzer, model numbers 393-800 and 393-801.
Reason for recall
The analyzer software may cause a mis-match of patient demographics and test results when a certain sequence of events occur.
Distribution pattern
Distribution was nationwide. There was also military/government distribution. Foreign distribution was made to Canada.
Code information
Model 393-800 ABL800 Series w/o Creatinin (All serial numbers) for the following configurations: ABL800, ABL805, ABL810, ABL815, ABL820, ABL825, ABL830, and ABL835. Model 393-801 ABL800 Series with Creatinin (All serial numbers) for the following configurations: ABL817, ABL827, and ABL837.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0682-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026